The outcome of thymectomy in nonthymomatous myasthenia gravis

M. H. Huang, K. L. King, W. H. Hsu, B. S. Huang, H. K. Hsu, L. S. Wang, K. Y. Chien

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

From October 1979 to December 1984, 77 patients with nonthymomatous myasthenia gravis underwent thymectomy and 74 patients were available for careful follow-up study in this review. Among these 74 patients, 18 were male and 56, female. Their ages ranged from 13 to 68 years with an average age of 30.2 years. Men tend to be affected at a later age than women (an average age of 38.0 versus 26.1 years). Duration of the disease was from one to 30 years, with an average of 4.2 years. A sternal-splitting incision was performed for all patients. Thymectomy was made by removal of all anterior mediastinal fat between the pleuropericardial reflection and phrenic nerve bilaterally. Seventy of the 74 patients benefited from thymectomy. Of these, 34 patients had remission and 36 patients had substantial improvement; three patients did not improve after thymectomy but did not increase in severity of symptoms or medication requirement. There was no postoperative death. Myasthenic crisis developed in four patients and five patients had pulmonary complications. These nine patients were among the 21 patients who did not receive either plasmapheresis preoperatively or a high dose of steroids perioperatively. Early thymectomy is recommended for patients with nonthymomatous myasthenia gravis. We also recommend that patients undergoing thymectomy should be treated either with plasmapheresis preoperatively or with high doses of steroid perioperatively.

Original languageEnglish
Pages (from-to)436-440
Number of pages5
JournalSurgery Gynecology and Obstetrics
Volume166
Issue number5
Publication statusPublished - 1988
Externally publishedYes

Fingerprint

Thymectomy
Myasthenia Gravis
Plasmapheresis
Steroids
Phrenic Nerve
Muscle Weakness

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Surgery

Cite this

Huang, M. H., King, K. L., Hsu, W. H., Huang, B. S., Hsu, H. K., Wang, L. S., & Chien, K. Y. (1988). The outcome of thymectomy in nonthymomatous myasthenia gravis. Surgery Gynecology and Obstetrics, 166(5), 436-440.

The outcome of thymectomy in nonthymomatous myasthenia gravis. / Huang, M. H.; King, K. L.; Hsu, W. H.; Huang, B. S.; Hsu, H. K.; Wang, L. S.; Chien, K. Y.

In: Surgery Gynecology and Obstetrics, Vol. 166, No. 5, 1988, p. 436-440.

Research output: Contribution to journalArticle

Huang, MH, King, KL, Hsu, WH, Huang, BS, Hsu, HK, Wang, LS & Chien, KY 1988, 'The outcome of thymectomy in nonthymomatous myasthenia gravis', Surgery Gynecology and Obstetrics, vol. 166, no. 5, pp. 436-440.
Huang MH, King KL, Hsu WH, Huang BS, Hsu HK, Wang LS et al. The outcome of thymectomy in nonthymomatous myasthenia gravis. Surgery Gynecology and Obstetrics. 1988;166(5):436-440.
Huang, M. H. ; King, K. L. ; Hsu, W. H. ; Huang, B. S. ; Hsu, H. K. ; Wang, L. S. ; Chien, K. Y. / The outcome of thymectomy in nonthymomatous myasthenia gravis. In: Surgery Gynecology and Obstetrics. 1988 ; Vol. 166, No. 5. pp. 436-440.
@article{4e4839b66f074a5ebcca28cc228941cb,
title = "The outcome of thymectomy in nonthymomatous myasthenia gravis",
abstract = "From October 1979 to December 1984, 77 patients with nonthymomatous myasthenia gravis underwent thymectomy and 74 patients were available for careful follow-up study in this review. Among these 74 patients, 18 were male and 56, female. Their ages ranged from 13 to 68 years with an average age of 30.2 years. Men tend to be affected at a later age than women (an average age of 38.0 versus 26.1 years). Duration of the disease was from one to 30 years, with an average of 4.2 years. A sternal-splitting incision was performed for all patients. Thymectomy was made by removal of all anterior mediastinal fat between the pleuropericardial reflection and phrenic nerve bilaterally. Seventy of the 74 patients benefited from thymectomy. Of these, 34 patients had remission and 36 patients had substantial improvement; three patients did not improve after thymectomy but did not increase in severity of symptoms or medication requirement. There was no postoperative death. Myasthenic crisis developed in four patients and five patients had pulmonary complications. These nine patients were among the 21 patients who did not receive either plasmapheresis preoperatively or a high dose of steroids perioperatively. Early thymectomy is recommended for patients with nonthymomatous myasthenia gravis. We also recommend that patients undergoing thymectomy should be treated either with plasmapheresis preoperatively or with high doses of steroid perioperatively.",
author = "Huang, {M. H.} and King, {K. L.} and Hsu, {W. H.} and Huang, {B. S.} and Hsu, {H. K.} and Wang, {L. S.} and Chien, {K. Y.}",
year = "1988",
language = "English",
volume = "166",
pages = "436--440",
journal = "Journal of the American College of Surgeons",
issn = "1072-7515",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - The outcome of thymectomy in nonthymomatous myasthenia gravis

AU - Huang, M. H.

AU - King, K. L.

AU - Hsu, W. H.

AU - Huang, B. S.

AU - Hsu, H. K.

AU - Wang, L. S.

AU - Chien, K. Y.

PY - 1988

Y1 - 1988

N2 - From October 1979 to December 1984, 77 patients with nonthymomatous myasthenia gravis underwent thymectomy and 74 patients were available for careful follow-up study in this review. Among these 74 patients, 18 were male and 56, female. Their ages ranged from 13 to 68 years with an average age of 30.2 years. Men tend to be affected at a later age than women (an average age of 38.0 versus 26.1 years). Duration of the disease was from one to 30 years, with an average of 4.2 years. A sternal-splitting incision was performed for all patients. Thymectomy was made by removal of all anterior mediastinal fat between the pleuropericardial reflection and phrenic nerve bilaterally. Seventy of the 74 patients benefited from thymectomy. Of these, 34 patients had remission and 36 patients had substantial improvement; three patients did not improve after thymectomy but did not increase in severity of symptoms or medication requirement. There was no postoperative death. Myasthenic crisis developed in four patients and five patients had pulmonary complications. These nine patients were among the 21 patients who did not receive either plasmapheresis preoperatively or a high dose of steroids perioperatively. Early thymectomy is recommended for patients with nonthymomatous myasthenia gravis. We also recommend that patients undergoing thymectomy should be treated either with plasmapheresis preoperatively or with high doses of steroid perioperatively.

AB - From October 1979 to December 1984, 77 patients with nonthymomatous myasthenia gravis underwent thymectomy and 74 patients were available for careful follow-up study in this review. Among these 74 patients, 18 were male and 56, female. Their ages ranged from 13 to 68 years with an average age of 30.2 years. Men tend to be affected at a later age than women (an average age of 38.0 versus 26.1 years). Duration of the disease was from one to 30 years, with an average of 4.2 years. A sternal-splitting incision was performed for all patients. Thymectomy was made by removal of all anterior mediastinal fat between the pleuropericardial reflection and phrenic nerve bilaterally. Seventy of the 74 patients benefited from thymectomy. Of these, 34 patients had remission and 36 patients had substantial improvement; three patients did not improve after thymectomy but did not increase in severity of symptoms or medication requirement. There was no postoperative death. Myasthenic crisis developed in four patients and five patients had pulmonary complications. These nine patients were among the 21 patients who did not receive either plasmapheresis preoperatively or a high dose of steroids perioperatively. Early thymectomy is recommended for patients with nonthymomatous myasthenia gravis. We also recommend that patients undergoing thymectomy should be treated either with plasmapheresis preoperatively or with high doses of steroid perioperatively.

UR - http://www.scopus.com/inward/record.url?scp=0023892437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023892437&partnerID=8YFLogxK

M3 - Article

C2 - 3363464

AN - SCOPUS:0023892437

VL - 166

SP - 436

EP - 440

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

SN - 1072-7515

IS - 5

ER -